{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T13:40:20Z","timestamp":1777124420277,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100020737","name":"Renji Hospital","doi-asserted-by":"publisher","award":["RJTJ23-PY-050"],"award-info":[{"award-number":["RJTJ23-PY-050"]}],"id":[{"id":"10.13039\/501100020737","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Accurate prenatal diagnosis of high-risk placenta accreta spectrum (PAS) is vital for maternal safety and can mitigate severe complications. We aimed to investigate the diagnostic value of a novel MRI sign, \u201cincreased intra-myometrial vascularity (IIMV),\u201d and to evaluate its contribution to an optimal MRI sign combination for differentiating high-risk placenta accreta spectrum (PAS), specifically placenta increta (PI) and percreta (PP), from placenta accreta (PA) or normal placenta. This retrospective study reviewed 166 high-risk pregnant women who underwent MRI. Two radiologists independently assessed the presence of the seven established risk signs from the SAR-ESUR consensus and the novel IIMV sign. The IIMV sign was defined as continuous tubular or tortuous flow-void structures confined within the myometrium, associated with architectural distortion. Univariate logistic regression and interobserver agreement (kappa statistics) were used to select significant signs, which were then incorporated into a multivariate model to construct diagnostic combinations. AUCs were compared between combinations (with and without IIMV sign) in differentiating PI\u2009+\u2009PP group from PA\u2009+\u2009Normal groups. The novel IIMV sign demonstrated the highest specificity (0.91) and was independently associated with the differentiation between the PI\u2009+\u2009PP and Normal\u2009+\u2009PA groups. The optimal sign combination, which included IIMV, placental bulge, myometrial thinning, and bladder wall interruption, achieved an area under the curve (AUC) of 0.84. In contrast, the combination without IIMV showed a decreased AUC of 0.79 (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.1203). The \u201cincreased intra-myometrial vascularity\u201d sign is a highly specific marker for high-risk PAS. Its inclusion in an MRI-based diagnostic model improves the performance for identifying invasive placental disorders compared to combinations that do not utilize this novel sign.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-33179-0","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T10:17:44Z","timestamp":1766398664000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Increased intra-myometrial vascularity adds diagnostic value to MRI for high-risk placenta accreta spectrum"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3980-2807","authenticated-orcid":false,"given":"Hainan","family":"Ren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weichun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijun","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianrong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"33179_CR1","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1002\/jmri.26592","volume":"50","author":"C Bourgioti","year":"2019","unstructured":"Bourgioti, C. et al. MRI prognosticators for adverse maternal and neonatal clinical outcome in patients at high risk for placenta accreta spectrum (PAS) disorders. Magn. Reson. Imaging. 50, 602\u2013618. https:\/\/doi.org\/10.1002\/jmri.26592 (2019).","journal-title":"Magn. Reson. Imaging"},{"key":"33179_CR2","doi-asserted-by":"publisher","first-page":"214","DOI":"10.2214\/AJR.16.16281","volume":"208","author":"A Kilcoyne","year":"2017","unstructured":"Kilcoyne, A. et al. MRI of placenta Accreta, placenta Increta, and placenta percreta: pearls and pitfalls. Am. J. Roentgenol. 208, 214\u2013221. https:\/\/doi.org\/10.2214\/AJR.16.16281 (2017).","journal-title":"Am. J. Roentgenol."},{"key":"33179_CR3","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/ijgo.12407","volume":"140","author":"E Jauniaux","year":"2018","unstructured":"Jauniaux, E., Chantraine, F., Silver, R. M. & Langhoff-Roos, J. For the FIGO placenta accreta diagnosis and management expert consensus panel FIGO consensus guidelines on placenta accreta spectrum disorders: epidemiology. Int. J. Gynecol. Obstet. 140, 265\u2013273. https:\/\/doi.org\/10.1002\/ijgo.12407 (2018).","journal-title":"Int. J. Gynecol. Obstet."},{"key":"33179_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/873929","volume":"2012","author":"G Garmi","year":"2012","unstructured":"Garmi, G. & Salim, R. Epidemiology, Etiology, Diagnosis, and management of placenta accreta. Obstet. Gynecol. Int. 2012, 1\u20137. https:\/\/doi.org\/10.1155\/2012\/873929 (2012).","journal-title":"Obstet. Gynecol. Int."},{"key":"33179_CR5","doi-asserted-by":"publisher","first-page":"5344","DOI":"10.1007\/s00261-021-03226-1","volume":"46","author":"H Ren","year":"2021","unstructured":"Ren, H. et al. Prediction of placenta accreta spectrum using texture analysis on coronal and sagittal T2-Weighted imaging. Abdom. Radiol. 46, 5344\u20135352. https:\/\/doi.org\/10.1007\/s00261-021-03226-1 (2021).","journal-title":"Abdom. Radiol."},{"key":"33179_CR6","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1007\/s00261-019-02008-0","volume":"44","author":"P Jha","year":"2019","unstructured":"Jha, P. et al. Placenta accreta spectrum: value of placental Bulge as a sign of myometrial invasion on MR imaging. Abdom. Radiol. 44, 2572\u20132581. https:\/\/doi.org\/10.1007\/s00261-019-02008-0 (2019).","journal-title":"Abdom. Radiol."},{"key":"33179_CR7","doi-asserted-by":"publisher","first-page":"1514e3","DOI":"10.1016\/j.fertnstert.2006.02.128","volume":"86","author":"M Alanis","year":"2006","unstructured":"Alanis, M., Hurst, B. S., Marshburn, P. B. & Matthews, M. L. Conservative management of placenta increta with selective arterial embolization preserves future fertility and results in a favorable outcome in subsequent pregnancies. Fertil. Steril. 86, 1514e3. 1514.e7 (2006).","journal-title":"Fertil. Steril."},{"key":"33179_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/FM9.0000000000000106","volume":"3","author":"E Jauniaux","year":"2021","unstructured":"Jauniaux, E., Zheng, W. & Yan, J. Confirming the diagnosis and classifying placenta accreta spectrum (PAS) disorders: minutes of 2020 online international workshop on PAS in Beijing. Maternal-Fetal Med. 3, 229\u2013231. https:\/\/doi.org\/10.1097\/FM9.0000000000000106 (2021).","journal-title":"Maternal-Fetal Med."},{"key":"33179_CR9","doi-asserted-by":"publisher","first-page":"837e1","DOI":"10.1016\/j.ajog.2021.12.030","volume":"226","author":"E Jauniaux","year":"2022","unstructured":"Jauniaux, E. et al. Searching for placenta percreta: A prospective cohort and systematic review of case reports. Am. J. Obstet. Gynecol. 226, 837e1. 837.e13 (2022).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"33179_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.2214\/AJR.11.7957","volume":"198","author":"JR Leyendecker","year":"2012","unstructured":"Leyendecker, J. R. et al. MRI of Pregnancy-Related issues: abnormal placentation. Am. J. Roentgenol. 198, 311\u2013320. https:\/\/doi.org\/10.2214\/AJR.11.7957 (2012).","journal-title":"Am. J. Roentgenol."},{"key":"33179_CR11","doi-asserted-by":"publisher","first-page":"S304","DOI":"10.1016\/j.ajog.2022.11.537","volume":"228","author":"E Licon","year":"2023","unstructured":"Licon, E. et al. The effect of MRI on surgical outcomes in subjects with placenta accreta spectrum. Am. J. Obstet. Gynecol. 228, S304. https:\/\/doi.org\/10.1016\/j.ajog.2022.11.537 (2023).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"33179_CR12","doi-asserted-by":"publisher","first-page":"1096175","DOI":"10.3389\/frph.2022.1096175","volume":"4","author":"JM Palacios-Jaraquemada","year":"2023","unstructured":"Palacios-Jaraquemada, J. M., Nieto-Calvache, \u00c1. J., Aryananda, R. A. & Basanta, N. Advantages of individualizing the placenta accreta spectrum management. Front. Reprod. Health. 4, 1096175. https:\/\/doi.org\/10.3389\/frph.2022.1096175 (2023).","journal-title":"Front. Reprod. Health"},{"key":"33179_CR13","unstructured":"Magnetic Resonance Imaging in. 300 Cases of Placenta Accreta\u2200 Surgical Correlation of New Findings.Pdf."},{"key":"33179_CR14","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1007\/s00330-019-06617-7","volume":"30","author":"P Jha","year":"2020","unstructured":"Jha, P. et al. Society of abdominal radiology (SAR) and European society of urogenital radiology (ESUR) joint consensus statement for MR imaging of placenta accreta spectrum disorders. Eur. Radiol. 30, 2604\u20132615. https:\/\/doi.org\/10.1007\/s00330-019-06617-7 (2020).","journal-title":"Eur. Radiol."},{"key":"33179_CR15","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1007\/s00261-017-1100-0","volume":"42","author":"T Sato","year":"2017","unstructured":"Sato, T. et al. Placental recess accompanied by a T2 dark band: A new finding for diagnosing placental invasion. Abdom. Radiol. 42, 2146\u20132153. https:\/\/doi.org\/10.1007\/s00261-017-1100-0 (2017).","journal-title":"Abdom. Radiol."},{"key":"33179_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.clinimag.2022.02.018","volume":"85","author":"H Ren","year":"2022","unstructured":"Ren, H., Mori, N., Mugikura, S. & Takase, K. Grading of placental accrete spectrum using texture analysis of magnetic resonance imaging. Clin. Imaging. 85, 8\u20139. https:\/\/doi.org\/10.1016\/j.clinimag.2022.02.018 (2022).","journal-title":"Clin. Imaging"},{"key":"33179_CR17","doi-asserted-by":"publisher","first-page":"685","DOI":"10.2214\/AJR.14.14134","volume":"205","author":"JM Horowitz","year":"2015","unstructured":"Horowitz, J. M. et al. When timing is everything: are placental MRI examinations performed before 24 weeks\u2019 gestational age reliable? Am. J. Roentgenol. 205, 685\u2013692. https:\/\/doi.org\/10.2214\/AJR.14.14134 (2015).","journal-title":"Am. J. Roentgenol."},{"issue":"1","key":"33179_CR18","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/ijgo.12761","volume":"146","author":"E Jauniaux","year":"2019","unstructured":"Jauniaux, E. et al. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int. J. Gynaecol. Obstet. 146 (1), 20\u201324. https:\/\/doi.org\/10.1002\/ijgo.12761 (2019).","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"33179_CR19","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/ijgo.12410","volume":"140","author":"L Sentilhes","year":"2018","unstructured":"Sentilhes, L., Kayem, G., Chandraharan, E., Palacios-Jaraquemada, J. & Jauniaux, E. For the FIGO placenta accreta diagnosis and management expert consensus panel FIGO consensus guidelines on placenta accreta spectrum disorders: Conservative management. Int. J. Gynecol. Obstet. 140, 291\u2013298. https:\/\/doi.org\/10.1002\/ijgo.12410 (2018).","journal-title":"Int. J. Gynecol. Obstet."},{"key":"33179_CR20","unstructured":"Invasive Placenta Previa\u2200. Placental bulge with distorted uterine outline and uterine serosal hypervascularity at 1.5T MRI \u2013 useful features for differentiating placenta percreta from placenta accreta.Pdf."},{"key":"33179_CR21","doi-asserted-by":"publisher","first-page":"701","DOI":"10.2214\/AJR.17.19303","volume":"211","author":"C Bourgioti","year":"2018","unstructured":"Bourgioti, C. et al. MRI features predictive of invasive placenta with extrauterine spread in High-Risk gravid patients: A prospective evaluation. Am. J. Roentgenol. 211, 701\u2013711. https:\/\/doi.org\/10.2214\/AJR.17.19303 (2018).","journal-title":"Am. J. Roentgenol."},{"key":"33179_CR22","doi-asserted-by":"publisher","unstructured":"Cuthbert, F., Teixidor Vinas, M. & Whitby, E. The MRI features of placental adhesion disorder\u2014a pictorial review. BJR 89 https:\/\/doi.org\/10.1259\/bjr.20160284 (2016).","DOI":"10.1259\/bjr.20160284"},{"key":"33179_CR23","unstructured":"Landis, J. R. G G Koch.  The measurement of observer agreement for categorical data."},{"key":"33179_CR24","unstructured":"Alireza, A. Shamshirsa maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach."},{"key":"33179_CR25","unstructured":"Parra-Herran, Carlos, M. D. & Djordjevic, Bojana, M. D. Histopathology of placenta creta: chorionic villi intrusion into myometrial vascular spaces and extravillous trophoblast proliferation are frequent and specific findings with implications for diagnosis and pathogenesis."},{"key":"33179_CR26","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1177\/1933719111426603","volume":"19","author":"HA Roeder","year":"2012","unstructured":"Roeder, H. A., Cramer, S. F. & Leppert, P. C. A look at uterine wound healing through a histopathological study of uterine scars. Reprod. Sci. 19, 463\u2013473. https:\/\/doi.org\/10.1177\/1933719111426603 (2012).","journal-title":"Reprod. Sci."},{"key":"33179_CR27","doi-asserted-by":"publisher","first-page":"399e1","DOI":"10.1016\/j.ajog.2021.08.056","volume":"226","author":"E Jauniaux","year":"2022","unstructured":"Jauniaux, E. et al. Development of the Utero-Placental circulation in Cesarean Scar pregnancies: A Case-Control study. Am. J. Obstet. Gynecol. 226, 399e1. 399.e10 (2022).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"33179_CR28","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.placenta.2020.11.004","volume":"104","author":"H Kapoor","year":"2021","unstructured":"Kapoor, H., Hanaoka, M., Dawkins, A. & Khurana, A. Review of MRI imaging for placenta accreta spectrum: pathophysiologic Insights, imaging Signs, and recent developments. Placenta 104, 31\u201339. https:\/\/doi.org\/10.1016\/j.placenta.2020.11.004 (2021).","journal-title":"Placenta"},{"key":"33179_CR29","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1007\/s43032-021-00763-4","volume":"29","author":"A Schwickert","year":"2022","unstructured":"Schwickert, A. et al. Placenta percreta presents with neoangiogenesis of arteries with von Willebrand Factor-Negative endothelium. Reprod. Sci. 29, 1136\u20131144. https:\/\/doi.org\/10.1007\/s43032-021-00763-4 (2022).","journal-title":"Reprod. Sci."},{"key":"33179_CR30","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.2214\/AJR.21.26317","volume":"217","author":"JM Palacios-Jaraquemada","year":"2021","unstructured":"Palacios-Jaraquemada, J. M. & Bruno, C. H. Placental bulging is only another sign in the placenta accreta spectrum diagnosis. Am. J. Roentgenol. 217, 1255\u20131255. https:\/\/doi.org\/10.2214\/AJR.21.26317 (2021).","journal-title":"Am. J. Roentgenol."},{"key":"33179_CR31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1053\/j.sult.2011.10.003","volume":"33","author":"D Nguyen","year":"2012","unstructured":"Nguyen, D., Nguyen, C., Yacobozzi, M., Bsat, F. & Rakita, D. Imaging of the placenta with pathologic correlation. Seminars Ultrasound CT MRI. 33, 65\u201377. https:\/\/doi.org\/10.1053\/j.sult.2011.10.003 (2012).","journal-title":"Seminars Ultrasound CT MRI"},{"key":"33179_CR32","doi-asserted-by":"crossref","unstructured":"Benirschke, K., Burton, G. J. & Baergen, R. N. Pathology of the Human Placenta. ISBN 978-3-642-23940-3. (Springer, 2012).","DOI":"10.1007\/978-3-642-23941-0"},{"key":"33179_CR33","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/uog.21872","volume":"55","author":"K Grewal","year":"2020","unstructured":"Grewal, K. et al. Natural history of Pregnancy\u2010related enhanced myometrial vascularity following miscarriage. Ultrasound Obstet. Gyne. 55, 676\u2013682. https:\/\/doi.org\/10.1002\/uog.21872 (2020).","journal-title":"Ultrasound Obstet. Gyne"},{"key":"33179_CR34","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/aogs.13374","volume":"97","author":"F D\u2019Antonio","year":"2018","unstructured":"D\u2019Antonio, F., Palacios-Jaraquemada, J., Timor\u2010Trisch, I. & Cali, G. Placenta accreta spectrum disorders: prenatal diagnosis still lacks clinical correlation. Acta Obstet. Gynecol. Scand. 97, 773\u2013775. https:\/\/doi.org\/10.1111\/aogs.13374 (2018).","journal-title":"Acta Obstet. Gynecol. Scand."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33179-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33179-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33179-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T12:59:12Z","timestamp":1777121952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33179-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["33179"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-33179-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"17 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45134"}}